Abstract 365P
Background
Nasopharyngeal carcinoma (NPC) is one of the most common malignancies in Malaysia and the incidence rate is high in the state of Sabah. Patients in Sabah are known to have limitations to access the healthcare services in the state. The purpose of this study is to examine the survival results, failure patterns, and compliance rate of patients with nasopharyngeal cancer who received radical radiotherapy with or without chemotherapy in Sabah.
Methods
A retrospective analysis was performed on patients diagnosed with stage I-IVA (AJCC staging 8th edition) NPC and treated with radiotherapy between the years of 2017-2019 in Sabah Women and Children's Hospital. The Kaplan-Meier method was used for survival analysis and differences in survival according to AJCC stage was compared using the log-rank test.
Results
A total of 140 patients were treated during this period. Most of them presented late at diagnosis, stage III (39%) and stage IVA (40%). Majority of them were treated with IMRT technique (85%). The compliance rate to radiotherapy was 96%. The 3-year overall survival (OS), disease-free-survival (DFS), local-failure-free survival (LFFS), regional-failure-free survival (RFFS), distant-failure-free survival (DFFS), of NPC patients in this study are 70%, 61%, 83%, 84%, and 67% respectively. The LFFS was significantly different between T stages (P value = 0.003) and T4 stage had the lowest rate of 3-year LFFS (65%). The RFFS was significantly different between N stages (P value = 0.013) and the 3-year RFFS probability for N3 stage was markedly lower than the rest (63%). The DFFS was significantly different between N stages (P-value < 0.001) and the 3-year DFFS probability decreased as N stage increased.
Conclusions
The 3-year OS and 3-year DFS rates in our study are comparable to those in peninsular Malaysia. The LFFS for T1-T3 stages is high. However, LFFS is low in T4 disease and DFFS is significantly low in N3 disease. Hence prospective studies are needed to determine if this group of patients may benefit from an intensified systemic treatment. Despite facing many challenges to access healthcare in Sabah, NPC patients in the state have a remarkably high compliance rate to radiotherapy treatment.
Clinical trial identification
NMRR ID-23-00055-E3N; RSCH ID-22-02599-GSk.
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
26P - Subcutaneous trastuzumab versus intravenous trastuzumab for treatment of patients with HER2-positive breast cancer: A time, motion and cost-benefit assessment in a day care oncology unit in China
Presenter: Bei Sun
Session: Poster Display
Resources:
Abstract
27P - The biological characteristics of HER2-low in TNBC using mRNA profiling and molecular subtypes
Presenter: Asako Tsuruga
Session: Poster Display
Resources:
Abstract
28P - One-week ultra-hypofractionated partial breast RT in early breast cancer: 3DCRT vs IMRT
Presenter: Nurilla Zaynutdinov
Session: Poster Display
Resources:
Abstract
30P - Stereotactic body radiotherapy using cyberknife versus interstitial brachytherapy in accelerated partial breast irradiation on left-sided breast: A comparison of preliminary clinical result and dosimetric characteristics
Presenter: Ting-Na Wei
Session: Poster Display
Resources:
Abstract
31P - Prognostic implication of breast edema on preoperative breast MRI in breast cancer
Presenter: Ki-tae Hwang
Session: Poster Display
Resources:
Abstract
32P - Efficacy of olanzapine in the prophylaxis of delayed chemotherapy-induced nausea and vomiting in breast cancer patients receiving dose-dense AC with a steroid-sparing regimen: A single-center pilot study
Presenter: Manami Tada
Session: Poster Display
Resources:
Abstract
34P - Social support as the mediator of the association between unmet needs and happiness among women with early breast cancer
Presenter: Nithiya Sinarajoo
Session: Poster Display
Resources:
Abstract
35P - Prospective study assessing the efficacy and safety of a scalp cooling device for the prevention of alopecia in breast cancer patients undergoing (neo)adjuvant chemotherapy
Presenter: Winnie Yeo
Session: Poster Display
Resources:
Abstract
37P - To excise or not to excise: Preventive management of early breast cancer in atypical ductal hyperplasia patients
Presenter: Clarisse Hing
Session: Poster Display
Resources:
Abstract
38P - Exploring prognostic factors in patients achieving PCR after neoadjuvant therapy for triple-negative breast cancer: A retrospective study based on SEER data
Presenter: Lv Wenjie
Session: Poster Display
Resources:
Abstract